ECS to acquire medicinal cannabis cultivator Murray Meds
Filed with ASX · · 4 pages · English
ECS to acquire Victoria-based Murray Meds, a fully licensed and permitted cannabis cultivator with TGA Good Manufacturing Practice (GMP) manufacture licence for dried flower, oils and tinctures Acquisition positions ECS to be one of Australia’s largest vertically integrated medicinal cannabis companies, with cultivation and revenues to be fast tracked Acquisition complements existing Tasmani
Ecs Botanics Holdings Ltd on 6ix
Earlier from Ecs Botanics
- ECS enters into term sheet with Medipharm Labs
- TGA Final Decision on Over-the-Counter CBD
- Proposed issue of Securities - ECS
- Response to ASX Price Query
- ECS Medicinal Cannabis Project and Regulatory Update
Later from Ecs Botanics
- Murray Meds signs European cannabis oil supply
- Murray Meds signs MOU with Australian based Cannabis Group
- Agreement to Supply Medicinal Cannabis
- Agreement to Supply Medicinal Cannabis (Amended)
- ECS successfully completes $4m raising
Follow Ecs Botanics into a list and get an email when it puts out news.
Follow Ecs Botanics